Jump Financial’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89M | Buy |
46,848
+28,632
| +157% | +$1.07M | 0.03% | 678 |
|
|
2025
Q4 | $634K | Buy |
+18,216
| New | +$1.43M | 0.01% | 1190 |
|
|
2025
Q3 | – | Sell |
-4,374
| Closed | -$321K | – | 1839 |
|
|
2025
Q2 | $321K | Buy |
+4,374
| New | +$317K | ﹤0.01% | 1378 |
|
|
2025
Q1 | – | Sell |
-14,242
| Closed | -$718K | – | 1641 |
|
|
2024
Q4 | $718K | Buy |
+14,242
| New | +$746K | 0.02% | 910 |
|
|
2024
Q3 | – | Sell |
-20,715
| Closed | -$673K | – | 1707 |
|
|
2024
Q2 | $673K | Sell |
20,715
-14,703
| -42% | -$403K | 0.01% | 996 |
|
|
2024
Q1 | $892K | Sell |
35,418
-13,808
| -28% | -$326K | 0.02% | 864 |
|
|
2023
Q4 | $1.6M | Buy |
+49,226
| New | +$1.35M | 0.05% | 491 |
|
|
2023
Q3 | – | Sell |
-32,300
| Closed | -$719K | – | 1903 |
|
|
2023
Q2 | $719K | Buy |
+32,300
| New | +$743K | 0.03% | 853 |
|
|
2023
Q1 | – | Sell |
-81,389
| Closed | -$1.65M | – | 1659 |
|
|
2022
Q4 | $1.65M | Buy |
81,389
+9,489
| +13% | +$238K | 0.09% | 311 |
|
|
2022
Q3 | $1.84M | Sell |
71,900
-20,806
| -22% | -$557K | 0.07% | 405 |
|
|
2022
Q2 | $2.21M | Buy |
92,706
+49,494
| +115% | +$1.08M | 0.09% | 287 |
|
|
2022
Q1 | $973K | Buy |
+43,212
| New | +$919K | 0.04% | 534 |
|
|
2021
Q4 | – | Sell |
-17,029
| Closed | -$335K | – | 1430 |
|
|
2021
Q3 | $335K | Buy |
+17,029
| New | +$356K | 0.02% | 614 |
|
|
2021
Q1 | – | Sell |
-28,752
| Closed | -$752K | – | 990 |
|
|
2020
Q4 | $752K | Buy |
+28,752
| New | +$606K | 0.13% | 247 |
|
Other funds holding CORT
ISL
VPM
VCM
PA